Conceivable Life Sciences

New York, NY · Founded 2022 · Privately Held (backing)

Developer of a fully automated AI-powered IVF lab designed to improve precision, quality, and scalability in fertility treatments. Conceivable Life Sciences is based in New York, NY and was founded in 2022. It was valued at $145 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $88.5 million across 3 recorded rounds; the latest was a $30.5 million early-stage round in Aug 2025.

PMV mark · valuation
$145.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$88.5M
Last round
Early Stage VC
Aug 2025

Who backs Conceivable Life Sciences?

13 investors
InvestorType
ACME CapitalVenture capital
Advance Venture PartnersVenture capital
Muse CapitalVenture capital
Black Opal VenturesVenture capital
Time BioVentures—
Atlantic Health SystemOther
ARTIS (San Francisco)—
Atlantic Health Venture Studio—
Cadence Healthcare Ventures—
Coriolis Ventures—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Conceivable Life Sciences investors

13 investors are on record for Conceivable Life Sciences, including ACME Capital, Advance Venture Partners, Muse Capital and Black Opal Ventures. The early-stage round in Aug 2025 drew 20 investors.

Free account
More of Conceivable Life Sciences with a free account
  • ·The complete investor list: 13 names
  • ·Watch Conceivable Life Sciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Conceivable Life Sciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View